NSCLC without actionable oncogenic alterations

Details

Files
Project Status:
Completed
Therapeutic Area:
Non-Small Cell Lung Cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0015-000

Review Type: Rapid

Provisional Funding Algorithm

Draft Report Posted: October 20, 2022
Stakeholder Feedback Deadline: October 27, 2022
Final Report Posted:   December 01, 2022